Position in TMO
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$3,569,181
+$45,404 QoQ
Shares Held
7,119
-0.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.98%
of 13F equity value
Holder Rank
#951
of 2,606 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026New Hampshire Trust holds $10,101,731 across 4 Diagnostics & Research names. TMO ranks #1 (35.3% of the industry book) .
All Filings in TMO
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,569,181 | 7,119 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $3,523,777 | 7,169 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $3,969,231 | 6,850 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $3,471,773 | 7,158 | Shares | Defined | 2025-10-16 | |
| 2025-06-30 | $2,721,852 | 6,713 | Shares | Defined | 2025-07-31 | |
| 2025-03-31 | $3,324,465 | 6,681 | Shares | Defined | 2025-04-08 | |
| 2024-12-31 | $3,312,303 | 6,367 | Shares | Defined | 2025-01-16 | |
| 2024-09-30 | $3,909,980 | 6,321 | Shares | Defined | 2024-10-17 | |
| 2024-06-30 | $3,513,762 | 6,354 | Shares | Defined | 2024-07-15 | |
| 2024-03-31 | $3,643,023 | 6,268 | Shares | Defined | 2024-04-09 | |
| 2023-12-31 | $3,290,367 | 6,199 | Shares | Defined | 2024-01-12 | |
| 2023-09-30 | $3,198,993 | 6,320 | Shares | Defined | 2023-10-17 | |
| 2023-06-30 | $3,259,372 | 6,247 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $3,688,191 | 6,399 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $3,755,705 | 6,820 | Shares | Sole | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||